CA3270055A1 - Vaccins à base de nanostructures de cylindre d'adn - Google Patents

Vaccins à base de nanostructures de cylindre d'adn

Info

Publication number
CA3270055A1
CA3270055A1 CA3270055A CA3270055A CA3270055A1 CA 3270055 A1 CA3270055 A1 CA 3270055A1 CA 3270055 A CA3270055 A CA 3270055A CA 3270055 A CA3270055 A CA 3270055A CA 3270055 A1 CA3270055 A1 CA 3270055A1
Authority
CA
Canada
Prior art keywords
nanostructure
vaccines
dna
barrel
nanostructure vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3270055A
Other languages
English (en)
Inventor
Yang C. ZENG
William M. Shih
James I. MacDonald
Ju Hee Ryu
Ick Chan Kwon
Original Assignee
Korea Institute of Science and Technology KIST
Dana Farber Cancer Institute Inc
Harvard University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Institute of Science and Technology KIST, Dana Farber Cancer Institute Inc, Harvard University filed Critical Korea Institute of Science and Technology KIST
Publication of CA3270055A1 publication Critical patent/CA3270055A1/fr
Pending legal-status Critical Current

Links

CA3270055A 2022-10-07 2023-10-06 Vaccins à base de nanostructures de cylindre d'adn Pending CA3270055A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63/414,380 2022-10-07
US63/489,561 2023-03-10

Publications (1)

Publication Number Publication Date
CA3270055A1 true CA3270055A1 (fr) 2024-04-11

Family

ID=

Similar Documents

Publication Publication Date Title
EP4045665A4 (fr) Trans-épissage d'arn amélioré par éditeur d'arn
EP3946369A4 (fr) Oligonucléotides modifiés à stabilité accrue
CA3293599A1 (en) Increasing tissue specific gene delivery by capsid modification
EP4213872A4 (fr) Vaccin à base de piv5 contre la covid-19
EP4051797A4 (fr) Hydrogel d'arn auto-assemblé commandé par adn programmé
EP4271803A4 (fr) Nickases guidées par acide nucléique
AU2021400063A1 (en) Rna construct
CA3270055A1 (fr) Vaccins à base de nanostructures de cylindre d'adn
EP4271805A4 (fr) Nouvelles nucléases guidées par acide nucléique
EP4171594A4 (fr) Vaccins à base de levure
EP4006908A4 (fr) Technique d'alignement de gènes
EP4342510A4 (fr) Seringue
EP4269592A4 (fr) Adn polymérase modifiée
AU2024301059A1 (en) Rna vaccines
AU2023902379A0 (en) RNA vaccines
HK40111185A (en) Rna vaccines
HK40102625A (en) Nucleic acid vaccines
HK40116357A (en) Dna revertase
HK40101560A (en) Rna vaccine against sars-cov-2 variants
CA3297100A1 (fr) Vaccin à arn combiné
HK40070097A (en) Nucleic acid based combination vaccines
HK40116093A (en) Sars-cov-2 vaccines
HK40115303A (en) Pancoronavirus vaccines
HK40087196A (en) Anti-coronavirus vaccines
HK40089951A (en) Sars-cov-2 vaccines